Content about Final

PARSIPPANY, N.J. — Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.

Watson is seeking approval for olopatadine hydrochloride ophthalmic solution in the 0.2% strength. The drug, used to treat itching in the eye resulting from allergic conjunctivitis, is a generic version of Alcon’s Pataday.

PITTSBURGH — Ore-Ida's Bagel Bites brand is asking consumers to take a pledge to commit to wholesome nutrition.

The brand's “Pledge to Snack Simply” online pledge asks parents to commit a few small steps that have a big impact on a child’s daily snack-time nutrition, the brand said. For each person who takes the pledge, Bagel Bites snacks will donate $1 to Boys & Girls Clubs of America, up to $50,000.

LAKE WORTH, Fla. — According to a post Monday from extreme couponer and Walgreens fan Christie Hardcastle, American Baby magazine is shipping out a Walgreens Infant Care Booklet mailer to subscribers.

“I wrote about these being mailed out in February but it looks like some of you might be getting this mailer again!” blogged Hardcastle. The mailer contains coupons for Nursery Water and Earth’s Best baby food, among other products, Hardcastle reported.

EMERYVILLE, Calif. — Clif Kid is extending its organic Zbar line with a new addition.

New Zbar Crispy is an organic rice-crispy snack that is made with 8 g of whole grains and a sprinkling of toasted oats for a lightly textured crunch. Available in three flavors, including chocolate, chocolate chip and peanut butter, Zbar Crispy retails for 89 cents per bar or $4.49 per six-pack box.

LOS ANGELES — Back-to-school shopping likely will take place even later this year than in 2010, as consumers hope to score last-minute deals, the latest forecast from PriceGrabber revealed.

PriceGrabber, a part of Experian, found that 95% of consumers are planning to use some sort of money-saving technique when back-to-school shopping, and they plan to start shopping later in 2011 than they did in 2010.

WASHINGTON — One week after the Senate failed to pass an amendment that would have delayed swipe-fee reform for an additional 12 months, the Department of Justice Antitrust Division reportedly is addressing anticompetitive practices related to credit cards.

The agency has submitted a final consent decree in its enforcement action against Visa and MasterCard, according to the Food Marketing Institute.

ROCKVILLE, Md. — The Food and Drug Administration on Monday announced that a consent decree of condemnation, forfeiture and permanent injunction has been filed against H&P Industries, Triad Group and three individuals, which would prevent them from manufacturing and distributing products from their Hartland, Wis., facility, or any other location.

JERUSALEM and FRAZER, Pa. — Before they can move ahead with their deal, drug makers Teva and Cephalon must provide the Federal Trade Commission with additional information related to Teva's pending acquisition of Cephalon.

INDIANAPOLIS — Drug maker Eli Lilly has created a multichannel platform to inform and educate patients about healthy eating, physical activity and stress management.

The program, Lilly for Better Health, is designed to help users live healthier, more active lives, and Lilly said it was designed to reach patients where they like to receive health information. The program includes a website, LillyForBetterHealth.com.

WASHINGTON — Retail spending for the month of May experienced a slight drop of 0.2% to $387.1 billion, though the advanced estimates noted that May sales were 7.7% higher than the year-ago period, the U.S. Census Bureau said Tuesday.

The government agency also reported that total sales for the March through May period were up 7.5% from the same period a year ago.

PURCHASE, N.Y. — PepsiCo said that it is ready to test market a new reduced-sugar cola.

The company said that its latest innovation, Pepsi Next, would be available in the Iowa and Wisconsin markets. The beverage offers consumers the taste of a full-calorie cola while touting less sugar, Pepsi said at the Beverage Digest Wall Street Smarts conference on Monday.

BRUSSELS — GlaxoSmithKline has garnered strong interest in its portfolio of legacy brands that were placed on the sales block earlier this year, according to a Reuters report published Tuesday. And that interest is likely to pick up in the coming months, GSK CEO Andrew Witty told reporters during a meeting of pharmaceutical industry executives.

The interest is coming from both established consumer healthcare companies, as well as private equity houses, the report noted.